178 related articles for article (PubMed ID: 8606082)
1. Cell growth rate regulates expression of group B Streptococcus type III capsular polysaccharide.
Paoletti LC; Ross RA; Johnson KD
Infect Immun; 1996 Apr; 64(4):1220-6. PubMed ID: 8606082
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cell component production by growth rate in the group B Streptococcus.
Ross RA; Madoff LC; Paoletti LC
J Bacteriol; 1999 Sep; 181(17):5389-94. PubMed ID: 10464211
[TBL] [Abstract][Full Text] [Related]
3. Use of a dynamic in vitro attachment and invasion system (DIVAS) to determine influence of growth rate on invasion of respiratory epithelial cells by group B Streptococcus.
Malin G; Paoletti LC
Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13335-40. PubMed ID: 11687649
[TBL] [Abstract][Full Text] [Related]
4. Fisher scientific award lecture - the capsular polysaccharides of Group B Streptococcus and Streptococcus suis differently modulate bacterial interactions with dendritic cells.
Segura M
Can J Microbiol; 2012 Mar; 58(3):249-60. PubMed ID: 22356626
[TBL] [Abstract][Full Text] [Related]
5. Role of L-ficolin/mannose-binding lectin-associated serine protease complexes in the opsonophagocytosis of type III group B streptococci.
Aoyagi Y; Adderson EE; Min JG; Matsushita M; Fujita T; Takahashi S; Okuwaki Y; Bohnsack JF
J Immunol; 2005 Jan; 174(1):418-25. PubMed ID: 15611266
[TBL] [Abstract][Full Text] [Related]
6. Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression.
Chaffin DO; Mentele LM; Rubens CE
J Bacteriol; 2005 Jul; 187(13):4615-26. PubMed ID: 15968073
[TBL] [Abstract][Full Text] [Related]
7. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
[TBL] [Abstract][Full Text] [Related]
8. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.
Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
Vaccine; 2000 Nov; 19(7-8):850-61. PubMed ID: 11115709
[TBL] [Abstract][Full Text] [Related]
9. Lectin site interaction with capsular polysaccharide mediates nonimmune phagocytosis of type III group B streptococci.
Albanyan EA; Edwards MS
Infect Immun; 2000 Oct; 68(10):5794-802. PubMed ID: 10992487
[TBL] [Abstract][Full Text] [Related]
10. Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development.
Bellais S; Six A; Fouet A; Longo M; Dmytruk N; Glaser P; Trieu-Cuot P; Poyart C
J Infect Dis; 2012 Dec; 206(11):1745-52. PubMed ID: 23002446
[TBL] [Abstract][Full Text] [Related]
11. Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk.
Lagergård T; Thiringer K; Wassén L; Schneerson R; Trollfors B
Eur J Pediatr; 1992 Feb; 151(2):98-102. PubMed ID: 1537371
[TBL] [Abstract][Full Text] [Related]
12. Identification of cpsD, a gene essential for type III capsule expression in group B streptococci.
Rubens CE; Heggen LM; Haft RF; Wessels MR
Mol Microbiol; 1993 May; 8(5):843-55. PubMed ID: 8355611
[TBL] [Abstract][Full Text] [Related]
13. Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R.
Hordnes K; Tynning T; Kvam AI; Bevanger L; Brown TA; Jonsson R; Haneberg B
Scand J Immunol; 1998 Feb; 47(2):179-88. PubMed ID: 9496695
[TBL] [Abstract][Full Text] [Related]
14. Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine.
Marques MB; Kasper DL; Shroff A; Michon F; Jennings HJ; Wessels MR
Infect Immun; 1994 May; 62(5):1593-9. PubMed ID: 8168919
[TBL] [Abstract][Full Text] [Related]
15. The serotype of type Ia and III group B streptococci is determined by the polymerase gene within the polycistronic capsule operon.
Chaffin DO; Beres SB; Yim HH; Rubens CE
J Bacteriol; 2000 Aug; 182(16):4466-77. PubMed ID: 10913080
[TBL] [Abstract][Full Text] [Related]
16. Identification of Group B Streptococcus Capsule Type by Use of a Dual Phenotypic/Genotypic Assay.
Alhhazmi A; Pandey A; Tyrrell GJ
J Clin Microbiol; 2017 Sep; 55(9):2637-2650. PubMed ID: 28615470
[TBL] [Abstract][Full Text] [Related]
17. Novel Multiplex Immunoassays for Quantification of IgG against Group B
Buffi G; Galletti B; Stella M; Proietti D; Balducci E; Romano MR; Mori E; Fabbrini M; Giuliani MM; Berti F; Margarit I
mSphere; 2019 Aug; 4(4):. PubMed ID: 31391276
[TBL] [Abstract][Full Text] [Related]
18. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.
Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I
Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816
[TBL] [Abstract][Full Text] [Related]
19. Capsular polysaccharide of Streptococcus agalactiae is an essential virulence factor for infection in Nile tilapia (Oreochromis niloticus Linn.).
Zhang D; Ke X; Liu Z; Cao J; Su Y; Lu M; Gao F; Wang M; Yi M; Qin F
J Fish Dis; 2019 Feb; 42(2):293-302. PubMed ID: 30549284
[TBL] [Abstract][Full Text] [Related]
20. Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine.
Paoletti LC; Wessels MR; Michon F; DiFabio J; Jennings HJ; Kasper DL
Infect Immun; 1992 Oct; 60(10):4009-14. PubMed ID: 1398913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
